Interestingly, recent research on the APP/PS1 mice with Alzheimer’s disease (AD) have demonstrated that CHZ daily administration during 23 days significantly improved the MWM performance of AD mice51. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.